Skip to main content

SYMFI

NDC 49502-475 · Viatris Specialty LLC

Generic nameEfavirenz, Lamivudine and Tenofovir Disoproxil Fumarate
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)EFAVIRENZ, LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE
Strength600; 300; 300 mg/1; mg/1; mg/1
Pharmacologic classCytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]
Marketing categoryNDA

Packages

49502-475-93 — 1 BOTTLE, PLASTIC in 1 CARTON (49502-475-93) / 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

42291-980 — Emtricitabine and Tenofovir Disoproxil Fumarate, 42385-801 — emtricitabine, rilpivirine and tenofovir disoproxil fumarate, 42385-915 — Efavirenz, emtricitabine and tenofovir disoproxil fumarate, 42385-928 — Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate, 42385-929 — Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate, 42385-953 — Emtricitabine and Tenofovir Disoproxil Fumarate, 42385-962 — Abacavir and Lamivudine, 42543-719 — EMTRICITABINE and TENOFOVIR Disoproxil Fumarate, 43063-900 — LAMIVUDINE and ZIDOVUDINE, 49502-450 — Lamivudine and Tenofovir Disoproxil Fumarate, 49702-202 — lamivudine and zidovudine, 49702-203 — lamivudine, 49702-204 — lamivudine, 49702-205 — lamivudine, 49702-231 — abacavir sulfate, dolutegravir sodium, lamivudine, 49702-246 — dolutegravir sodium and lamivudine, 50090-6494 — Emtricitabine and Tenofovir Disoproxil Fumarate, 50090-7202 — Tenofovir Disoproxil Fumarate, 50090-7719 — Emtricitabine and tenofovir disoproxil fumarate, 50090-8028 — Emtricitabine and tenofovir disoproxil fumarate, +125 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels